Abstract Three-dimensional (3D) bioprinting holds the promise to fabricate tissue and organ
substitutes for regenerative medicine. However, the lack of bioactive inks to fabricate and …

Abstract 3D bioprinting is a rapidly emerging technology to manufacture biological tissue
constructs that more closely recapitulate physiological features of native tissue, and thus …

Biomaterial-associated microbial contaminations in biologically conducive three-
dimensional (3D) tissue-engineered constructs have significantly limited the clinical …

Bioprinting aims to provide new avenues for regenerating damaged human tissues through
the controlled printing of live cells and biocompatible materials that can function …

The development of extrusion-based bioprinting for tissue engineering is conditioned by the
design of bioinks displaying adequate printability, shape stability, and postprinting …

Abstract 3D bioprinting technology has been an interest in constructing tissue engineering
scaffolds due to its high resolution and repeatability, ability to fabricate complex construct …

The complexity of biological architectures (tissue or organ) attracts extensive use of additive
manufacturing techniques for tissue engineering scaffolding. A step forward, to ensure …

Advanced bioinks for 3D printing are rationally designed materials intended to improve the
functionality of printed scaffolds outside the traditional paradigm of the “biofabrication …

Pectin has found extensive interest in biomedical applications, including wound dressing,
drug delivery, and cancer targeting. However, the low viscosity of pectin solutions hinders …

Three-dimensional (3D) bioprinting is an emerging tissue engineering approach that aims to
develop cell or biomolecule-laden, complex polymeric scaffolds with high precision, using …